期刊文献+

喹唑啉类PAK4小分子抑制剂影响胰腺癌细胞迁移及侵袭的作用机制 被引量:1

The mechanism of quinazoline PAK4 small molecule inhibitor affecting the migration and invasion of pancreatic cancer cells
下载PDF
导出
摘要 目的:探究喹唑啉类PAK4小分子抑制剂Czh#226对胰腺癌细胞增殖、迁移等方面的作用。方法:四唑盐比色法(MTT)检测不同浓度的Czh#226对胰腺癌细胞增殖的影响;Transwell实验检测不同浓度Czh#226对胰腺癌细胞迁移的影响;激光扫描共聚焦显微(Confocal)实验检测不同浓度Czh#226对胰腺癌细胞微丝的影响;Western blot实验检测不同浓度Czh#226对胰腺癌细胞PAK4激酶的活化及其下游迁移侵袭相关蛋白的表达。结果:Czh#226对胰腺癌细胞的增殖无抑制作用,但在5μmol/L时对迁移及侵袭能力有明显抑制作用;Czh#226对PAK4激酶的活性以及PAK4下游细胞骨架相关靶蛋白的磷酸化亦有抑制作用,且均呈剂量效应关系。结论:Czh#226是通过抑制PAK4激酶的活性以及PAK4下游细胞骨架相关靶蛋白的表达来抑制微丝的重组,从而抑制胰腺癌细胞的迁移及侵袭能力。 Objective:To investigate the effects of the quinazoline PAK4 small molecule inhibitor Czh#226 on the proliferation and migration of pancreatic cancer cells lines.Methods:MTT tetrazolium salt colorimetry was used to detect the effects of different concentrations of Czh#226 on the proliferation of pancreatic cancer cells.The effect of different concentrations of Czh#226 on the migration of pancreatic cancer cells was detected by Transwell assay.Confocal assay was used to detect different concentrations of Czh#226 on pancreatic cancer cells ’microfilaments.Western blot assay was used to detect the expression of the activation of PAK4 and the proteins related with migration and invasion in pancreatic cancer cells by different concentrations of Czh#226.Results:Czh#226 had no inhibitory effect on the proliferation of pancreatic cancer cells,but it could inhibit the migration and invasion of pancreatic cancer cells at 5 μmol/L.It also inhibited the expression of the activity of PAK4 kinase and the downstream of PAK4 proteins related with cytoskeleton,and all of them showed a dose-effect relationship.Conclusion:Czh#226 inhibits the reorganization of microfilaments by inhibiting the expression of the activity of PAK4 kinase and the downstream proteins of PAK4 which related to cytoskeleton,thereby inhibiting the migration and invasion of pancreatic cancer cells.
作者 路天琦 李晓东 Lu Tianqi;Li Xiaodong(Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology y Minis try of Education, China Medical University, Liaoning Shenyang 1101229 China)
出处 《现代肿瘤医学》 CAS 2019年第17期2983-2987,共5页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81230077)
关键词 PAK4 胰腺癌 小分子抑制剂 迁移 侵袭 PAK4 pancreatic cancer small molecule inhibitor migration invasion
  • 相关文献

参考文献3

二级参考文献7

  • 1Tripathy D.Overview:gemcitabine as single- agent therapy for advanced breast cancer[J].Clin Breast Cancer,2002,3 (Suppl) 1:8- 11.
  • 2Colucci G,Giuliani F,Gebbia V,et al.Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and /or metastatic pancreatic carcinoma:a prospective,randomized phase Ⅲ study of the Gruppo Oncologiadell' Italia Meridionale [J].Cancer,2002,94(4):902- 910.
  • 3Roychowdhury DF,Cassidy CA,Peterson P, et al. A report on serious pulmonar toxicity with Gemcitabine- based therapy[J]. Invest New Drugs,2002,20(3):311- 315.
  • 4Ronld KL,Richard PG,Cees J van Groeningen, et al. Severe acute lung injury induced by gemcitabine[J]. The Netherlander Journal of Medicine, 2000,56:232- 235.
  • 5管忠震,陈茹琴,徐光川,李宇红,许立功,李龙云,刘叙仪,廖美琳,李金瀚.Gemcitabine治疗晚期非小细胞肺癌的临床研究[J].癌症,1999,18(3):241-245. 被引量:177
  • 6秦叔逵,李进.阿帕替尼治疗胃癌的临床应用专家共识[J].临床肿瘤学杂志,2015,20(9):841-847. 被引量:352
  • 7赵成龙,傅昌芳.阿帕替尼致消化道出血[J].世界最新医学信息文摘,2015,15(A0). 被引量:10

共引文献42

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部